BARCELONA, Spain — One-year results with the second-generation ELZA-sub400 protocol for corneal cross-linking showed efficacy in halting keratoconus progression in ultrathin corneas, according to a study presented here.
“The second-generation ELZA-sub400 protocol presents an updated accelerated approach to managing progressive keratoconus in patients with ultrathin corneas. One-year follow-up data look promising,” Emilio Torres-Netto, MD, PhD, said at the European Society of Cataract and Refractive Surgeons meeting.
The study included 29 eyes with pre-irradiation corneal